What's new

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 68, Status: Authorised

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 68, Status: Authorised

May 16, 2025 - 13:14
 0
Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 68, Status: Authorised
Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 68, Status: Authorised
Read More

Tags:

Previous Article

Novo Nordisk boss ousted as Ozempic maker battles profit slump

Next Article

Human medicines European public assessment report (EPAR): Flucelvax, influenza v...

Related Posts

Human medicines European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan), clopidogrel,acetylsalicylic acid, Date of authorisation: 09/01/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 5, 2025  0

Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 11:00 (CET) to 18 November 2025, 12:00 (CET)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0